ConductScience.org, home

Library / Trials

Multicomponent Exercise in People With Dementia

NCT04951258, Not applicable, Unknown, National Yang Ming Chiao Tung University

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleMulticomponent Exercise in People With DementiaClinicalTrials.gov
NCT numberNCT04951258ClinicalTrials.gov
StatusUnknownClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment52 participants, estimatedClinicalTrials.gov
Lead sponsorNational Yang Ming Chiao Tung UniversityClinicalTrials.gov
ConditionsDementiaClinicalTrials.gov
InterventionsMulticomponent exercise, Video home exercise groupClinicalTrials.gov
First posted2021-07-06ClinicalTrials.gov
Last updated2021-08-24ClinicalTrials.gov

Registered outcomes 12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryMini-Mental State ExaminationChange from baseline at 9 weekIt is a 30-point questionnaire that is used extensively in clinical and research settings to measure cognitive impairment. Higher scores mean a better outcome.ClinicalTrials.gov
PrimaryChinese version of Verbal learning testChange from baseline at 9 weekIt is a 9-point measurement to evaluate memory. Higher scores mean a better outcome.ClinicalTrials.gov
PrimaryChinese version of Stroop color and word testChange from baseline at 9 weekIt is a measurement to evaluate inhibition control.ClinicalTrials.gov
PrimaryDigit span testChange from baseline at 9 weekIt is a measurement to evaluate working memory.ClinicalTrials.gov
PrimaryTrail making test - Chinese versionChange from baseline at 9 weekIt is a measurement to evaluate cognitive flexibility.ClinicalTrials.gov
SecondaryBarthel indexChange from baseline at 9 weekIt is a 100-point ordinal scale used to measure performance in activities of daily living. Higher scores mean a better outcome.ClinicalTrials.gov
SecondaryInstrumental activities of daily living (IADL) scaleChange from baseline at 9 weekIt is a 24-point ordinal scale used to measure performance in instrumental activities of daily living. Higher scores mean a better outcome.ClinicalTrials.gov
SecondaryChinese version of Quality of Life in Alzheimer Disease ScaleChange from baseline at 9 weekIt is a measurement to evaluate quality of life. The scale scores range from 13 to 52, with higher scores indicating greater quality of life.ClinicalTrials.gov
SecondaryTime up and go testChange from baseline at 9 weekIt is a test to evaluate functional mobility.ClinicalTrials.gov
Secondary30-second chair stand testChange from baseline at 9 weekIt is a test to evaluate muscle strength.ClinicalTrials.gov
Secondary6-minute walk testChange from baseline at 9 weekIt is a test to evaluate endurance.ClinicalTrials.gov
SecondaryBerg Balance ScaleChange from baseline at 9 week
It is a tool to evaluate balance. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function.
ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 5

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Digit Span TestPrimary outcomeConductCognition
Stroop Color-Word TestPrimary outcomeConductCognition
Trail Making Test APrimary outcomeConductCognition
Trail Making Test BPrimary outcomeConductCognition
Verbal LearningPrimary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)